Stock Analiz

Veracyte, Inc. (VCYT) stock forecast and price target

Price $24.33 · data as of November 13, 2026

12-month price target

Average target$44.60
Upside / downside+83.3%
Analysts10
ConsensusBuy
Low $30.00Average $44.60High $65.00

Gold marker: average target · white marker: today’s price ($24.33)

Analyst ratings

Strong buy 2Buy 7Hold 3Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$1.94+9.2%$591M
Next fiscal year
ends December 31, 2027
$1.57−19.4%$634M
Next quarter
ends December 31, 2026
$0.38−27.7%$150M
Quarter after
ends March 31, 2027
$0.33−35.9%$148M

Consensus of the analysts covering Veracyte, updated daily. In the last 30 days 2 estimates were raised and 0 lowered.

Our model vs. Wall Street

Analysts see 83.3% upside over 12 months. Our discounted cash flow model with moderate assumptions puts Veracyte’s intrinsic value about 41% below today’s market value, and it scores 2.6 out of 5 on our checks. Price targets follow sentiment; a DCF follows cash. When both point the same way the signal is stronger. Try your own assumptions.

Frequently asked questions

What is the Veracyte stock price target?

The average 12-month target from 10 analysts is $44.60, 83.3% above the current price of $24.33 Targets range from $30.00 to $65.00.

Is Veracyte a buy according to analysts?

The consensus rating is “Buy” (2 strong buy, 7 buy, 3 hold). Ratings are opinions, not guarantees; this is not investment advice.

How much is Veracyte expected to earn?

Analysts expect EPS of $1.94 for the fiscal year ending December 31, 2026 and $1.57 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.